Changes in PCSK 9 and apolipoprotein B100 in Niemann–Pick disease after enzyme replacement therapy with olipudase alfa

被引：0
|
作者：
Bethanie Garside
Jan Hoong Ho
See Kwok
Yifen Liu
Shaishav Dhage
Rachelle Donn
Zohaib Iqbal
Simon A. Jones
Handrean Soran
机构：
[1] University of Manchester,Lipid Research Group, Division of Cardiovascular Sciences
[2] Manchester University NHS Foundation Trust,Cardiovascular Trials Unit, Manchester Royal Infirmary
[3] University of Manchester,Faculty of Biology, Medicine and Health
[4] Manchester University NHS Foundation Trust,Manchester Centre for Genomic Medicine, St Marys Hospital
来源：
Orphanet Journal of Rare Diseases | / 16卷
关键词：
Acid sphingomyelinase deficiency; Apolipoprotein B100; Proprotein convertase subtilisin/klexin type 9; Tumour necrosis factor α; Low density lipoprotein cholesterol; Enzyme replacement therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 33 条
  • [21] Effects of growth hormone (GH) replacement therapy on very low density lipoprotein apolipoprotein B100 kinetics in patients with adult GH deficiency:: A stable isotope study
    Christ, ER
    Cummings, MH
    Albany, E
    Umpleby, AM
    Lumb, PJ
    Wierzbicki, AS
    Naoumova, RP
    Boroujerdi, MA
    Sönksen, PH
    Russell-Jones, DL
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (01): : 307 - 316
  • [22] AAV vector-mediated enzyme replacement therapy is efficacious in reversing storage pathology and preventing Purkinje cell death in a mouse model of Niemann-Pick A disease
    Passini, MA
    Bu, J
    Dodge, JC
    Zhao, Q
    Taksir, TV
    Collins, HA
    O'Riordan, CR
    Stewart, GR
    MOLECULAR THERAPY, 2004, 9 : S81 - S81
  • [23] A phase 1 trial of recombinant human acid Sphingomyelinase (rhASM) Enzyme replacement therapy in adults with Non-Neuronopathic ASM deficiency (ASMD Niemann-Pick B)
    McGovern, Margaret
    Wasserstein, Melissa
    Kirmse, Brian
    Duvall, Lane
    Schiano, Thomas
    Thurberg, Beth
    Richards, Susan
    Cox, Gerald
    MOLECULAR GENETICS AND METABOLISM, 2011, 102 (02) : S28 - S28
  • [24] PCSK9 inhibitor therapy in homozygous familial defective apolipoprotein B-100 due to APOB R3500Q: A case report
    Andersen, Lars
    Davis, Tina
    Testa, Heidi
    Andersen, Rolf L.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2017, 11 (06) : 1471 - 1474
  • [25] Mannose 6-phosphate receptor-mediated uptake is defective in acid sphingomyelinase-deficient macrophages - Implications for Niemann-Pick disease enzyme replacement therapy
    Dhami, R
    Schuchman, EH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (02) : 1526 - 1532
  • [26] Clathrin-Mediated Endocytosis Is Impaired in Type A-B Niemann-Pick Disease Model Cells and Can Be Restored by ICAM-1-Mediated Enzyme Replacement
    Rappaport, Jeff
    Garnacho, Carmen
    Muro, Silvia
    MOLECULAR PHARMACEUTICS, 2014, 11 (08) : 2887 - 2895
  • [27] Adults with chronic acid sphingomyelinase deficiency show significant visceral, pulmonary, and hematologic improvements after enzyme replacement therapy with olipudase-alfa: 1-year results of the ASCEND placebo-controlled trial
    Wasserstein, Melissa
    Arash-Kaps, Laila
    Barbato, Antonio
    Gallagher, Renata C.
    Giugliani, Roberto
    Guelbert, Norberto B.
    Hollak, Carla
    Ikezoe, Takayuki
    Lachmann, Robin
    Lidove, Oliver
    Mabe, Paulina
    Mengel, Eugen
    Scarpa, Maurizio
    Senates, Ebubekir
    Tchan, Michel
    Villarrubia, Jesus
    Chen, Yixin
    Fraser, Patricia A.
    Thurberg, Beth L.
    Zaher, Atef
    Kumar, Monica
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : S110 - S110
  • [28] Gene therapy for the treatment of Niemann-Pick disease type C1: Comparison of AAV9 to a novel serotype, AAV-PHP.B
    Davidson, Cristin
    Gibson, Alana
    Gu, Tansy
    Chandler, Randy
    Deverman, Benjamin
    Gradinaru, Viviana
    Venditti, Charles
    Pavan, William
    MOLECULAR GENETICS AND METABOLISM, 2018, 123 (02) : S36 - S37
  • [29] Body composition and 6 minute walking ability in late-onset pompe disease patients after 9 years of enzyme replacement therapy
    Terzis, Gerasimos
    Papadimas, Georgios
    Krase, Argyro
    Kontou, Eleni
    Arnaoutis, Ioannis
    Papadopoulos, Constantinos
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2022, 132 (07) : 699 - 705
  • [30] Long-term changes in arterial structure and function and left ventricular geometry after enzyme replacement therapy in patients affected with Fabry disease
    Collin, Cedric
    Briet, Marie
    Thi-Chien Tran
    Beaussier, Helene
    Benistan, Karelle
    Bensalah, Mourad
    Mousseaux, Elie
    Froissart, Marc
    Bozec, Erwan
    Laurent, Stephane
    Boutouyrie, Pierre
    Germain, Dominique P.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2012, 19 (01) : 43 - 54
1234